相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis
Francesca Ruffini et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis
Shalini Kumar et al.
NEUROBIOLOGY OF DISEASE (2013)
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
Wolfgang Brueck et al.
ACTA NEUROPATHOLOGICA (2012)
Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
Jan Thoene et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Cortical Remyelination: A New Target for Repair Therapies in Multiple Sclerosis
Ansi Chang et al.
ANNALS OF NEUROLOGY (2012)
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
Rina Aharoni et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis
Mario Mangiardi et al.
BRAIN PATHOLOGY (2011)
Levels of BDNF Impact Oligodendrocyte Lineage Cells following a Cuprizone Lesion
Melissa W. VonDran et al.
JOURNAL OF NEUROSCIENCE (2011)
Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials
David Bates
NEUROLOGY (2011)
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Ranjan Dutta et al.
PROGRESS IN NEUROBIOLOGY (2011)
Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis
Ralf A. Linker et al.
BRAIN (2010)
Oestrogen receptor β ligand: a novel treatment to enhance endogenous functional remyelination
Daniel K. Crawford et al.
BRAIN (2010)
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
Christiane Wegner et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: In-vitro high-throughput gene expression study
M. Gurevich et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE
Marina O. Ziehn et al.
LABORATORY INVESTIGATION (2010)
MRI of the corpus callosum in multiple sclerosis: association with disability
A. Ozturk et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Brain-Derived Neurotrophic Factor Promotes Central Nervous System Myelination via a Direct Effect upon Oligodendrocytes
Junhua Xiao et al.
NEUROSIGNALS (2010)
Lower Motor Neuron Loss in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Johannes Vogt et al.
ANNALS OF NEUROLOGY (2009)
Transgenic Inhibition of Astroglial NF-κB Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation
Roberta Brambilla et al.
JOURNAL OF IMMUNOLOGY (2009)
Assaying the functional effects of demyelination and remyelination: Revisiting field potential recordings
Daniel K. Crawford et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
Purkinje cell loss in experimental autoimmune encephalomyelitis
Allan MacKenzie-Graham et al.
NEUROIMAGE (2009)
New oral drugs for multiple sclerosis
Claudio Gasperini et al.
NEUROLOGICAL SCIENCES (2009)
FUNCTIONAL RECOVERY OF CALLOSAL AXONS FOLLOWING DEMYELINATION: A CRITICAL WINDOW
D. K. Crawford et al.
NEUROSCIENCE (2009)
Function of Neurotrophic Factors Beyond the Nervous System: Inflammation and Autoimmune Demyelination
Ralf A. Linker et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
Callosal function in MS patients with mild and severe callosal damage as reflected by diffusion tensor imaging
Nele P. Warlop et al.
BRAIN RESEARCH (2008)
Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis
M. V. Jones et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
G. Comi et al.
LANCET (2008)
Diffusion weighted callosal integrity reflects interhemispheric communication efficiency in multiple sclerosis
Nele P. Warlop et al.
NEUROPSYCHOLOGIA (2008)
Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing -: remitting experimental autoimmune encephalomyelitis
Stine Rasmussen et al.
BRAIN (2007)
Differential neuroprotective and anti inflammatory effects of estrogen receptor (ER)α and ERβ ligand treatment
Seema Tiwari-Woodruff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis
David A. Brown et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis
Lawrence Steinman et al.
ANNALS OF NEUROLOGY (2006)
Myelinated and unmyelinated axons of the corpus callosum differ in vulnerability and functional recovery following traumatic brain injury
TM Reeves et al.
EXPERIMENTAL NEUROLOGY (2005)
Motor neuron pathology in experimental autoimmune encephalomyelitis:: studies in THY1-YFP transgenic mice
PG Bannerman et al.
BRAIN (2005)
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
C Polman et al.
NEUROLOGY (2005)
IFN-γ determines distinct clinical outcomes in autoimmune encephalomyelitis
AK Wensky et al.
JOURNAL OF IMMUNOLOGY (2005)
Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis
M Hobom et al.
BRAIN PATHOLOGY (2004)
Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-β in Lewis rats
HS Yang et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Evidence of early cortical atrophy in MS relevance to white matter changes and disability
N De Stefano et al.
NEUROLOGY (2003)
The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephomyelitis
C Brunmark et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP
GP Feng et al.
NEURON (2000)
分享论文
